SCHEMBL19695933

SCHEMBL19695933

COc1cc(/C=C/c2nc3ccccc3[nH]c2=O)ccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 11/20 0.65
▸ MEN1 O00255 9/20 0.65
▸ MAPT P10636 8/20 0.65
▸ NPC1 O15118 7/20 0.65
▸ RAB9A P51151 7/20 0.65
▸ KDM4E B2RXH2 6/20 0.65
▸ GAA P10253 5/20 0.65
▸ TDP1 Q9NUW8 2/20 0.65
▸ POLB P06746 3/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ TLR9 Q9NR96 1/20 0.61
▸ ALDH1A1 P00352 3/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ HPGD P15428 2/20 0.56
▸ GFER P55789 1/20 0.56
▸ USP2 O75604 2/20 0.55
▸ MAPK10 P53779 1/20 0.55
▸ APP P05067 1/20 0.52
▸ LMNA P02545 1/20 0.51
▸ ALOX12 P18054 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1900840 0.90 KMT2A (0.68) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL1900841 0.90 KMT2A (0.68) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL17498778 0.81 HDAC1 (0.55) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL9607124 0.80 KMT2A (0.57) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL6936350 0.76 RAB9A (0.78) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL7105109 0.76 RAB9A (0.78) KMT2AMEN1MAPTNPC1RAB9A
Vanillin SCHEMBL28367299 0.76 ALDH1A1 (0.58) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL28465286 0.76 KMT2A (1.00) KMT2AMEN1MAPTNPC1RAB9A
Curcumin SCHEMBL12988139 0.75 APP (0.64) KMT2AMEN1MAPTKDM4EGAA
SCHEMBL28471161 0.74 MEN1 (0.48) KMT2AMEN1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9839640-B2 Methods of treating eye diseases associated with inflammation and vascular proliferation OCCURX PTY LTD (AU) 2017-12-12 — — US disclosed
Send feedback